170 related articles for article (PubMed ID: 10397613)
1. Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin.
Schwarb FP; Imanidis G; Smith EW; Haigh JM; Surber C
Pharm Res; 1999 Jun; 16(6):909-15. PubMed ID: 10397613
[TBL] [Abstract][Full Text] [Related]
2. Stratum corneum absorption kinetics of 2 potent topical corticosteroid formulations: a pilot study.
Draelos ZD
Cutis; 2015 Aug; 96(2):135-41. PubMed ID: 26367752
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay.
Pershing LK; Silver BS; Krueger GG; Shah VP; Skelley JP
Pharm Res; 1992 Jan; 9(1):45-51. PubMed ID: 1589409
[TBL] [Abstract][Full Text] [Related]
4. Formulation issues associated with transdermal fentanyl delivery.
Santos P; Watkinson AC; Hadgraft J; Lane ME
Int J Pharm; 2011 Sep; 416(1):155-9. PubMed ID: 21723931
[TBL] [Abstract][Full Text] [Related]
5. Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action.
Yamane MA; Williams AC; Barry BW
J Pharm Pharmacol; 1995 Dec; 47(12A):978-89. PubMed ID: 8932680
[TBL] [Abstract][Full Text] [Related]
6. The effect of formulation excipients on the penetration and lateral diffusion of ibuprofen on and within the stratum corneum following topical application to humans.
Gee CM; Watkinson AC; Nicolazzo JA; Finnin BC
J Pharm Sci; 2014 Mar; 103(3):909-19. PubMed ID: 24421242
[TBL] [Abstract][Full Text] [Related]
7. Effect of propylene glycol on ibuprofen absorption into human skin in vivo.
Herkenne C; Naik A; Kalia YN; Hadgraft J; Guy RH
J Pharm Sci; 2008 Jan; 97(1):185-97. PubMed ID: 17497726
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability.
Wiedersberg S; Naik A; Leopold CS; Guy RH
Br J Dermatol; 2009 Mar; 160(3):676-86. PubMed ID: 18782322
[TBL] [Abstract][Full Text] [Related]
9. Topical 0.050% betamethasone dipropionate. Pharmacokinetic and pharmacodynamic dose-response studies in humans.
Pershing LK; Lambert L; Wright ED; Shah VP; Williams RL
Arch Dermatol; 1994 Jun; 130(6):740-7. PubMed ID: 8002644
[TBL] [Abstract][Full Text] [Related]
10. Vehicles based on a sugar surfactant: Colloidal structure and its impact on in vitro/in vivo hydrocortisone permeation.
Savić SD; Savić MM; Vesić SA; Vuleta GM; Müller-Goymann CC
Int J Pharm; 2006 Aug; 320(1-2):86-95. PubMed ID: 16730932
[TBL] [Abstract][Full Text] [Related]
11. Optimisation of cosolvent concentration for topical drug delivery - II: influence of propylene glycol on ibuprofen permeation.
Watkinson RM; Guy RH; Hadgraft J; Lane ME
Skin Pharmacol Physiol; 2009; 22(4):225-30. PubMed ID: 19648784
[TBL] [Abstract][Full Text] [Related]
12. Supersaturation: enhancement of skin penetration and permeation of a lipophilic drug.
Moser K; Kriwet K; Froehlich C; Kalia YN; Guy RH
Pharm Res; 2001 Jul; 18(7):1006-11. PubMed ID: 11496937
[TBL] [Abstract][Full Text] [Related]
13. Vehicle design for a new topical steroid, fluocinonide.
Ostrenga J; Haleblian J; Poulsen B; Ferrell B; Mueller N; Shastri S
J Invest Dermatol; 1971 May; 56(5):392-9. PubMed ID: 5556528
[No Abstract] [Full Text] [Related]
14. An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: the influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation.
Savić S; Savić M; Tamburić S; Vuleta G; Vesić S; Müller-Goymann CC
Eur J Pharm Sci; 2007 Apr; 30(5):441-50. PubMed ID: 17331708
[TBL] [Abstract][Full Text] [Related]
15. Influence of penetration enhancer on drug permeation from volatile formulations.
Santos P; Watkinson AC; Hadgraft J; Lane ME
Int J Pharm; 2012 Dec; 439(1-2):260-8. PubMed ID: 23000063
[TBL] [Abstract][Full Text] [Related]
16. Comparative permeation studies of nondiluted and diluted betamethasone-17-valerate semisolid formulations through isolated human stratum corneum and artificial skin construct.
Mitriaikina S; Muller-Goymann CC
Skin Pharmacol Physiol; 2009; 22(3):142-50. PubMed ID: 19246962
[TBL] [Abstract][Full Text] [Related]
17. Relative influence of ethanol and propylene glycol cosolvents on deposition of minoxidil into the skin.
Tata S; Weiner N; Flynn G
J Pharm Sci; 1994 Oct; 83(10):1508-10. PubMed ID: 7884676
[TBL] [Abstract][Full Text] [Related]
18. Drug and vehicle deposition from topical applications: use of in vitro mass balance technique with minoxidil solutions.
Tsai JC; Cappel MJ; Flynn GL; Weiner ND; Kreuter J; Ferry JJ
J Pharm Sci; 1992 Aug; 81(8):736-43. PubMed ID: 1403715
[TBL] [Abstract][Full Text] [Related]
19. Topical corticosteroid compounding: effects on physicochemical stability and skin penetration rate.
Krochmal L; Wang JC; Patel B; Rodgers J
J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):979-84. PubMed ID: 2808834
[TBL] [Abstract][Full Text] [Related]
20. The influence of volatile solvents on transport across model membranes and human skin.
Oliveira G; Hadgraft J; Lane ME
Int J Pharm; 2012 Oct; 435(1):38-49. PubMed ID: 22634140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
